GL1X · GenesisL1 explorer

Research workbench

Crystal structure of methanocaldococcus jannaschii TRM5 in complex with adenosine

Analyse Crystal structure of methanocaldococcus jannaschii TRM5 in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3AY0
Type
protein
Length
634 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uncharacterized protein MJ0883
UniProt
Q58293
Ligands
ADN, ZN
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUncharacterized protein MJ0883protein32028% helix, 33% strandQ58293
BUncharacterized protein MJ0883protein31426% helix, 30% strandQ58293

Ligands and binding sites

  • ADN · Adenosine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19860.770.7982ZN, ADN
21930.710.8720empty
34260.650.7847ADN
4590.270.7415empty

Interfaces

1 interface between chains.

  • A–B · 211 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 3AY0 · Crystal structure of Methanocaldococcus jannaschii Trm5 in complex with adenosine · the same entry in another collection · chain A against A, TM-score 1.00
  • Q58293 · AlphaFold monomer V2.0 prediction for tRNA (GUANINE(37)-N1)-methyltransferase TRM5B… · a predicted model of the same protein · chain B against A, TM-score 0.79

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.